title: Highlights from the 39th Annual meeting of the American Society of Clinical Oncology Chicago, Illinois.
authors.forename: Preeta
authors.initials: P
authors.lastname: Tyagi
authors.forename: Jennifer
authors.initials: J
authors.lastname: Klem
authors.forename: Amy
authors.initials: A
authors.lastname: D'Orazio
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D000077143:Docetaxel; D034261:Epothilones / Q000627:therapeutic use*; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008495:Medical Oncology; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D043823:Taxoids / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D034261:Epothilones; D043823:Taxoids; D017273:Goserelin; D000077143:Docetaxel; C093788:epothilone B